The Charlotte Post3h
Sickest patients face insurance denials despite policy fixes
Ekirch said specialists have suggested that a series of infusions made from blood plasma called intravenous immunoglobulin — ...
The Cigna Group (NYSE:CI) Receives $373.25 Average PT from Brokerages
The Cigna Group (NYSE:CI – Get Free Report) has been assigned a consensus rating of “Buy” from the seventeen research firms that are presently covering the firm, Ratings reports. Two research analysts ...
'They won’t help me': Sickest patients face insurance denials despite policy fixes
Ekirch said specialists have suggested that a series of infusions made from blood plasma called intravenous immunoglobulin -- ...
The Cigna Group: Compelling Exposure To Diversified Healthcare At A Discount Price
Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.